FI95912C - Menetelmä terapeuttisesti aktiivisten pyrido/2,3-f//1,4/tiatsepiini- ja pyrido/3,2-b//1,5/bentsotiatsepiinijohdannaisten valmistamiseksi - Google Patents
Menetelmä terapeuttisesti aktiivisten pyrido/2,3-f//1,4/tiatsepiini- ja pyrido/3,2-b//1,5/bentsotiatsepiinijohdannaisten valmistamiseksiInfo
- Publication number
- FI95912C FI95912C FI912124A FI912124A FI95912C FI 95912 C FI95912 C FI 95912C FI 912124 A FI912124 A FI 912124A FI 912124 A FI912124 A FI 912124A FI 95912 C FI95912 C FI 95912C
- Authority
- FI
- Finland
- Prior art keywords
- pyrido
- thiazepine
- preparation
- therapeutically active
- benzothiazepine derivatives
- Prior art date
Links
- 229940085242 benzothiazepine derivative selective calcium channel blockers with direct cardiac effects Drugs 0.000 title 1
- 150000007657 benzothiazepines Chemical class 0.000 title 1
- DRRWPYNMKWQKIB-UHFFFAOYSA-N pyrido[2,3-b][1,4]thiazepine Chemical compound S1C=CC=NC2=CC=CN=C12 DRRWPYNMKWQKIB-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229940127291 Calcium channel antagonist Drugs 0.000 abstract 1
- 230000001088 anti-asthma Effects 0.000 abstract 1
- 239000000924 antiasthmatic agent Substances 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- JROBKLYZJGATCR-UHFFFAOYSA-N pyrido[2,3-f][1,4]thiazepine Chemical class S1C=CN=CC2=NC=CC=C12 JROBKLYZJGATCR-UHFFFAOYSA-N 0.000 abstract 1
- BYUYCWQSIZPKCS-UHFFFAOYSA-N pyrido[3,2-b][1,5]benzothiazepine Chemical class C1=NC2=CC=CC=C2SC2=CC=CN=C21 BYUYCWQSIZPKCS-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Reproductive Health (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Luminescent Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/518,351 US5075440A (en) | 1990-05-03 | 1990-05-03 | Novel pyrido[2,3-f](1,4)thiazepines and pyrido[3,2-b](1,5)benzothiazepines |
| US51835190 | 1990-05-03 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI912124A0 FI912124A0 (fi) | 1991-05-02 |
| FI912124A FI912124A (fi) | 1991-11-04 |
| FI95912B FI95912B (fi) | 1995-12-29 |
| FI95912C true FI95912C (fi) | 1996-04-10 |
Family
ID=24063558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI912124A FI95912C (fi) | 1990-05-03 | 1991-05-02 | Menetelmä terapeuttisesti aktiivisten pyrido/2,3-f//1,4/tiatsepiini- ja pyrido/3,2-b//1,5/bentsotiatsepiinijohdannaisten valmistamiseksi |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US5075440A (fi) |
| EP (1) | EP0462696B1 (fi) |
| JP (1) | JP3296499B2 (fi) |
| KR (1) | KR100195345B1 (fi) |
| CN (2) | CN1034077C (fi) |
| AT (1) | ATE126231T1 (fi) |
| AU (1) | AU651580B2 (fi) |
| CA (1) | CA2041594C (fi) |
| DE (1) | DE69111915T2 (fi) |
| DK (1) | DK0462696T3 (fi) |
| ES (1) | ES2079570T3 (fi) |
| FI (1) | FI95912C (fi) |
| GR (1) | GR3017305T3 (fi) |
| HK (1) | HK51496A (fi) |
| HU (1) | HU218909B (fi) |
| IE (1) | IE68524B1 (fi) |
| IL (6) | IL97999A (fi) |
| MY (1) | MY106552A (fi) |
| NO (1) | NO179411C (fi) |
| NZ (1) | NZ237988A (fi) |
| PT (1) | PT97547B (fi) |
| TN (1) | TNSN91030A1 (fi) |
| TW (1) | TW218878B (fi) |
| ZA (1) | ZA913319B (fi) |
| ZW (1) | ZW5291A1 (fi) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6593335B1 (en) * | 1997-12-18 | 2003-07-15 | Abbott Laboratories | Potassium channel openers |
| IL135985A0 (en) * | 1997-12-18 | 2001-05-20 | Abbott Lab | Potassium channel openers |
| US6265417B1 (en) | 1997-12-18 | 2001-07-24 | Abbott Laboratories | Potassium channel openers |
| JPH11193289A (ja) | 1997-12-26 | 1999-07-21 | Suntory Ltd | ピロールスルホンアミド誘導体 |
| US6482854B1 (en) * | 1999-03-25 | 2002-11-19 | Massachusetts Eye And Ear Infirmary | Glaucoma treatment |
| US7015212B1 (en) | 1999-05-12 | 2006-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Thiazepine inhibitors of HIV-1 integrase |
| JP2003502335A (ja) | 1999-06-14 | 2003-01-21 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | ジチエピノ［６，５−ｂ］ピリジンおよび関連組成物および方法 |
| ATE302206T1 (de) * | 1999-07-12 | 2005-09-15 | Ortho Mcneil Pharm Inc | Oxathiepino(6,5-b)dihydropyridine und verwandte verbindungen und verfahren |
| US6472530B1 (en) | 1999-09-22 | 2002-10-29 | Ortho-Mcneil Pharmaceutical, Inc. | Benzo-fused dithiepino[6,5-b]pyridines, and related compositions and methods |
| JP2003519626A (ja) | 2000-01-12 | 2003-06-24 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | カルシウムアンタゴニスト活性を有するベンゾスルホン類 |
| EP1257554A1 (en) | 2000-01-27 | 2002-11-20 | Ortho-McNeil Pharmaceutical, Inc. | Benzoxathiepino[3,4-b]pyridine derivatives, process for their preparation and their use as medicaments |
| DE60103261T2 (de) | 2000-03-23 | 2005-06-02 | Ortho-Mcneil Pharmaceutical, Inc. | Thiepino[3,2-b]dihydropyridine und relatierte zusammensetzungen und verfahren |
| CN1680324A (zh) | 2000-05-30 | 2005-10-12 | 奥索-麦克尼尔药品公司 | 二氢吡啶软药及相关组合物和方法 |
| KR101233139B1 (ko) | 2011-04-21 | 2013-02-21 | 주식회사 한서켐 | 라세믹 1,4-티아제핀 화합물의 분할 방법 |
| EP3240547A4 (en) * | 2014-12-30 | 2018-06-13 | Myotherix Inc. | Novel calcium modulators |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1587128A (en) * | 1977-04-07 | 1981-04-01 | Hexachimie | Benzothiazepine derivatives |
| US4285955A (en) * | 1978-10-31 | 1981-08-25 | Bayer Aktiengesellschaft | 1,4-Dihydropyridinecarboxylic acids |
| NZ201395A (en) * | 1981-07-30 | 1987-02-20 | Bayer Ag | Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines |
| FR2511683A1 (fr) * | 1981-08-20 | 1983-02-25 | Hexachimie | Nouveaux derives de la pyrido (2,3-b) benzothiazepine(1,5) substituee en 5 par une carboxypiperazine, leur procede de preparation, leur application en therapeutique |
| EP0225175A3 (en) * | 1985-11-28 | 1988-12-28 | FISONS plc | Dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions thereof |
-
1990
- 1990-05-03 US US07/518,351 patent/US5075440A/en not_active Expired - Lifetime
-
1991
- 1991-04-29 IL IL97999A patent/IL97999A/xx not_active IP Right Cessation
- 1991-04-29 IL IL12704798A patent/IL127047A0/xx unknown
- 1991-04-29 IL IL12044797A patent/IL120447A/xx not_active IP Right Cessation
- 1991-04-29 IL IL12704791A patent/IL127047A/xx not_active IP Right Cessation
- 1991-04-29 IL IL12044697A patent/IL120446A0/xx unknown
- 1991-04-29 IL IL12044691A patent/IL120446A/xx not_active IP Right Cessation
- 1991-04-29 NZ NZ237988A patent/NZ237988A/xx unknown
- 1991-05-01 CA CA002041594A patent/CA2041594C/en not_active Expired - Fee Related
- 1991-05-02 EP EP91303970A patent/EP0462696B1/en not_active Expired - Lifetime
- 1991-05-02 ZW ZW52/91A patent/ZW5291A1/xx unknown
- 1991-05-02 HU HU476/91A patent/HU218909B/hu not_active IP Right Cessation
- 1991-05-02 ES ES91303970T patent/ES2079570T3/es not_active Expired - Lifetime
- 1991-05-02 MY MYPI91000748A patent/MY106552A/en unknown
- 1991-05-02 NO NO911723A patent/NO179411C/no unknown
- 1991-05-02 KR KR1019910007086A patent/KR100195345B1/ko not_active IP Right Cessation
- 1991-05-02 AU AU76354/91A patent/AU651580B2/en not_active Ceased
- 1991-05-02 PT PT97547A patent/PT97547B/pt not_active IP Right Cessation
- 1991-05-02 JP JP13047291A patent/JP3296499B2/ja not_active Expired - Fee Related
- 1991-05-02 DE DE69111915T patent/DE69111915T2/de not_active Expired - Fee Related
- 1991-05-02 ZA ZA913319A patent/ZA913319B/xx unknown
- 1991-05-02 DK DK91303970.7T patent/DK0462696T3/da active
- 1991-05-02 FI FI912124A patent/FI95912C/fi active
- 1991-05-02 IE IE148891A patent/IE68524B1/en not_active IP Right Cessation
- 1991-05-02 AT AT91303970T patent/ATE126231T1/de not_active IP Right Cessation
- 1991-05-03 TN TNTNSN91030A patent/TNSN91030A1/fr unknown
- 1991-05-03 CN CN91103594A patent/CN1034077C/zh not_active Expired - Fee Related
- 1991-07-20 TW TW080105637A patent/TW218878B/zh active
-
1995
- 1995-07-29 CN CN95109346A patent/CN1039416C/zh not_active Expired - Fee Related
- 1995-09-06 GR GR950402432T patent/GR3017305T3/el unknown
-
1996
- 1996-03-21 HK HK51496A patent/HK51496A/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI95912C (fi) | Menetelmä terapeuttisesti aktiivisten pyrido/2,3-f//1,4/tiatsepiini- ja pyrido/3,2-b//1,5/bentsotiatsepiinijohdannaisten valmistamiseksi | |
| FI91529B (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten pyrido/1,2,3-de//1,4/bentsoksatsiinijohdannaisten valmistamiseksi | |
| FI92828C (fi) | Menetelmä valmistaa terapeuttisesti arvokasta 5,11-dihydro-6H-dipyrido/3,2-b:2',3'-e/ /1,4/diatsepin-6-onia | |
| HU902994D0 (en) | Process for the preparation of diazabicyclic compounds | |
| FI871535A (fi) | Menetelmä terapeuttisesti aktiivisten tiasykloalkeno/3,2-b/pyridiinien valmistamiseksi | |
| HUT45072A (en) | Process for producing 2-substituted-4-deoxy-thiazolo /5,4-c/rifamycin-sv-derivatives and pharmaceutically acceptable acid-addition salts thereof | |
| OA09487A (fr) | "Procédé de préparation de nouvelles pyrrolo (1,2-a)thiéno (3,2-f) diazépines(1,4)". | |
| FI912247A (fi) | Menetelmä terapeuttisesti käyttökelpoisten pyrrolo/2,3-b/indoliketonijohdannaisten valmistamiseksi | |
| NZ235080A (en) | Pyrido(2,3-b)(1,5)benz(ox- or thi-)azepinones and pharmaceutical compositions thereof | |
| FI914681A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten N-alkenyylibentso/b/tieno-/3,2-b/oksatsiini-2,4-dionien valmistamiseksi | |
| HU901581D0 (en) | Process for the preparation of 1,3-substituted tetrahydro-1h-thieno[3,4-d]imidazol-2/3h/-on-4-ylidene-pentanoic acid ester | |
| FI904244A0 (fi) | Menetelmä valmistaa terapeuttisesti tehokkaita pyrido-/2,3-b//1,5/bentsoksatsepin- ja tiatsepin-5-(6H)oneja | |
| LV5737A4 (lv) | Tetrahidro-1H-piridoÚ4,3-b¾indol-1-ona atvasinajumi | |
| FI93837C (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 4-okso-4,5-dihydro-imidatso/1,5-a/pyrido/2,3-e/pyratsiinijohdannaisten valmistamiseksi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application |